Ask your Senators to Support S. 2113!

Rate this post
  1. Get in touch with your Legislators today to sustain regulations to accelerate medication and also treatment approvals.
  2. Earlier this week, Senator Kay Hagan (D-NC) presented Us senate Costs 2113, the Transforming the Regulatory Setting to Accelerate Accessibility to Therapies (TREAT) Act.

The Parkinson’s Action Network (PAN) supports this expense, a favorable step in the effort to guarantee the Food and Drug Administration (FDA) has at its disposal the required devices and also sources to getting secure and efficient therapies faster to patients who need them.

As you recognize, existing, state-of-the-art therapy for Parkinson’s is based on a 40-year-old pharmaceutical treatment, which only deals with some signs of the illness. No treatments exist that will slow or stop its development. Furthermore, central homepage nerve system drugs, consisting of treatments for Parkinson’s illness, are the slowest in the medicine growth pipeline– it takes approximately 15-20 years for new treatments to reach market.

This bill is meant to enhance and improve the authorization process to ensure people with Parkinson’s and other chronic diseases have quicker access to risk-free and efficient treatments.

Please ask your Legislators to co-sponsor S. 2113, the Changing the Regulatory Atmosphere to Accelerate Access to Therapies (TREAT) Act.